TOPEKA (KSNT) – The Kansas Department of Health and Environment announced that Kansas will resume distributing the Johnson & Johnson COVID-19 vaccine following an announcement on April 23 from the Centers for Disease Control and Prevention and the Food and Drug Administration encouraging resumption of the vaccine.
“Today, Kansas will resume administering the Johnson & Johnson COVID-19 vaccine,” said Governor Laura Kelly. “After a brief pause and a thorough review, the CDC and FDA have determined the vaccine is safe and effective. Whether it’s the Johnson and Johnson, Pfizer or Moderna, I strongly encourage every Kansan to get vaccinated as soon as they can.”
The Johnson & Johnson vaccine was paused after a very small percentage of women developed adverse side effects that included blood clots and low platelets, also known as thrombosis-thrombocytopenia syndrome.
“The federal government will continue studying links between the vaccine and the rare blood clotting disorder,” Kelly said. “Those who have received the Johnson & Johnson vaccine should contact their health care provider if they have any symptoms and report any illness to the VAERS Reporting System.”
To visit the CDC’s Vaccine Adverse Event Reporting System, click here: https://vaers.hhs.gov.